ホーム › 多発性骨髄腫 › ニュージャージー › Edison
Edison、NJにおける多発性骨髄腫の臨床試験
Edisonとその周辺地域（約30マイル以内）の拠点で、多発性骨髄腫に関する22件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第3相
- Astera Cancer Care, East Brunswick · 6マイル先
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
被験者募集中第3相
- Astera Cancer Care, East Brunswick · 6マイル先
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
被験者募集中第3相
- MSK Basking Ridge, Basking Ridge · 15マイル先
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
被験者募集中第4相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
被験者募集中第3相
- MSK Basking Ridge, Basking Ridge · 15マイル先
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
被験者募集中第1相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
被験者募集中第3相
- Research Site, East Brunswick · 6マイル先
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
被験者募集中観察研究
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
被験者募集中第1/2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
被験者募集中早期第1相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · 3マイル先
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
被験者募集中第1/2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
被験者募集中第1相
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · 3マイル先
A Dietary Study for People With Multiple Myeloma
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
被験者募集中第1/2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
被験者募集中
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
他の都市における多発性骨髄腫の試験
- New York City, NY60件の研究
- Boston, MA42件の研究
- Atlanta, GA41件の研究
- Houston, TX38件の研究
- Durham, NC37件の研究
- Nashville, TN32件の研究
- Denver, CO27件の研究
- Rochester, MN24件の研究
- St. Louis, MO24件の研究
- Columbus, OH24件の研究
- Baldwin Park, CA23件の研究
- Chicago, IL22件の研究
Edisonにおける他の研究
- 乳がん68件の研究
- 非小細胞肺癌47件の研究
- がん（全種類）33件の研究
- 前立腺がん29件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 膀胱癌21件の研究
- 転移性癌20件の研究
- 卵巣がん20件の研究
- 急性骨髄性白血病20件の研究
- 子宮内膜がん19件の研究
- 尿路上皮（移行上皮）癌18件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。